FOLD icon

Amicus Therapeutics

257 hedge funds and large institutions have $2.74B invested in Amicus Therapeutics in 2021 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 96 increasing their positions, 77 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

less funds holding

Funds holding:

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

17% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 63

58% less capital invested

Capital invested by funds: $6.44B → $2.74B (-$3.71B)

Holders
257
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26.6M
Puts
$21.6M
Net Calls
Net Calls Change

Top Sellers

1 -$154M
2 -$31.2M
3 -$31.1M
4
Morgan Stanley
Morgan Stanley
New York
-$27.3M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$26.3M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$692K
127
$675K
128
$642K
129
$625K
130
$623K
131
$622K
132
$588K
133
$585K
134
$583K
135
$559K
136
$554K
137
$522K
138
$487K
139
$482K
140
$467K
141
$466K
142
$459K
143
$455K
144
$450K
145
$436K
146
$435K
147
$404K
148
$391K
149
$375K
150
$362K